AKT1 and breast carcinoma: Therefore, the present study focused on the regulation of the PI3K/AKT signaling pathway and macrophage polarization by SORBS1 to inhibit EMT in breast cancer, with the aim of discovering potential drug targets for the clinical treatment of this disease.